These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30475084)

  • 1. The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: implications for targeting tumour-initiating cells.
    Jhaveri A; Luther E; Torchilin V
    J Drug Target; 2019; 27(5-6):601-613. PubMed ID: 30475084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
    Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness.
    Richichi C; Osti D; Del Bene M; Fornasari L; Patanè M; Pollo B; DiMeco F; Pelicci G
    Oncotarget; 2016 Nov; 7(44):71491-71503. PubMed ID: 27582543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
    Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
    Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.
    Rosa P; Sforna L; Carlomagno S; Mangino G; Miscusi M; Pessia M; Franciolini F; Calogero A; Catacuzzeno L
    J Cell Physiol; 2017 Sep; 232(9):2478-2488. PubMed ID: 27606467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
    Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
    Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility.
    Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T
    J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model.
    Lakkadwala S; Singh J
    J Pharm Sci; 2018 Nov; 107(11):2902-2913. PubMed ID: 30055226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC20 maintains tumor initiating cells.
    Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
    Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review.
    Kawak P; Sawaftah NMA; Pitt WG; Husseini GA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.